You are not alone. Right now, in and on your body, approximately 38 trillion microorganisms are going about their business—bacteria, archaea, viruses, fungi, and other microscopic life forms that collectively constitute your microbiome. These aren't invaders or parasites (mostly); they're residents, many of them ancient partners in an evolutionary relationship stretching back millions of years. By cell count, microbial cells in your body roughly equal the number of your own human cells. By gene count, the comparison is even more striking: the human genome contains around 20,000 genes, whilst your gut bacteria alone carry an estimated 3.3 million unique genes. You are, in a very real sense, more microbial than human.
This isn't merely a curiosity. The microbiome—particularly the community inhabiting your gut—turns out to influence an extraordinary range of bodily functions: digestion, immune function, mental health, metabolic rate, susceptibility to disease, response to medicines, and possibly even personality and behaviour. The implications are profound and are generating some of the most exciting and contentious research in all of medicine. Over the last two decades, the gut microbiome has gone from obscure academic interest to one of the most intensely studied systems in human biology, with connections drawn to conditions ranging from obesity and diabetes to depression, autism, Parkinson's disease, and cancer.
What Exactly Is the Microbiome?
The term "microbiome" refers to the collective genome of microorganisms in a particular environment—though in common usage it refers to both the organisms themselves and their genes. The microbiota refers specifically to the organisms. Your body hosts several distinct microbial communities: on skin, in the mouth, in the vagina, in the lungs, and most densely and diversely, in the gut.
The gut microbiome—the community inhabiting your large intestine primarily—is the most studied and most significant. Here, in approximately 1.5 litres of content within your colon, live an estimated 1,000+ species of bacteria, interacting with each other, with your gut cells, and with your immune system in a complex ecosystem. This community collectively weighs about 1.5 kilograms—comparable to your liver.
The composition of this community varies enormously between individuals—studies find that two random people share perhaps 40% of their gut bacterial species. It varies with diet, geography, age, antibiotic use, stress levels, and many other factors. It even varies within a single person from day to day. This variability makes studying the microbiome both fascinating and technically challenging: there is no single "healthy microbiome" but rather a range of diverse communities that seem to support health through functional redundancy—many different bacterial species can perform similar roles.
Studying the microbiome at scale became possible only in the early 2000s, with the development of next-generation DNA sequencing techniques. Previously, microbial identification required culturing organisms in laboratory conditions—but more than 70% of gut bacteria cannot be grown outside the gut. Sequencing DNA directly from faecal samples (without culturing the bacteria) revealed a microbial world of staggering diversity that had been essentially invisible to science.
What Your Gut Bacteria Do
The microbiome isn't a passive community of hitchhikers. Its members are metabolically active, performing functions your own cells cannot—and in some cases wouldn't survive without.
Digestion and nutrition: Human digestive enzymes cannot break down complex plant carbohydrates—the dietary fibre in vegetables, wholegrains, and legumes. Gut bacteria can. They ferment these fibres, producing short-chain fatty acids (SCFAs)—particularly butyrate, propionate, and acetate—that are absorbed and used for energy. Butyrate is the primary fuel for the cells lining your colon; without adequate gut bacteria producing it, colonic cells struggle to function. SCFAs also influence metabolism throughout the body: they signal to the liver, fat tissue, and even the brain, affecting appetite, blood glucose regulation, and inflammatory responses.
Some bacteria synthesise vitamins that humans cannot produce—particularly vitamin K2 and certain B vitamins including biotin, folate, and B12. The contribution of gut bacteria to vitamin B12 levels in particular is significant; vegetarians and vegans with healthy gut microbiomes may produce more B12 internally than has historically been appreciated.
Immune education: Approximately 70% of the human immune system is located in the gut—specifically in gut-associated lymphoid tissue (GALT) that wraps around the intestines. This isn't coincidental. The gut is the largest interface between the body's interior and the external world (via food and drink), and training the immune system to distinguish beneficial microbes and food proteins from genuine pathogens requires constant, complex communication between gut bacteria and immune cells.
This begins at birth. Studies show that babies born by Caesarean section, who don't pass through the vaginal canal and receive its microbial inoculation, have different microbiome compositions in their early months and higher rates of certain immune conditions, including asthma and allergies. Early antibiotic use disrupts this microbial education during a critical developmental window, which may partly explain the rising rates of allergic and autoimmune conditions in populations with high antibiotic use. The "hygiene hypothesis"—the idea that reduced childhood exposure to microbes contributes to immune dysregulation—finds mechanistic support in microbiome research.
Metabolic regulation: The gut microbiome influences metabolic rate and fat storage in ways that startled researchers when first discovered. Landmark experiments showed that germ-free mice (raised in sterile conditions without gut bacteria) are significantly leaner than normal mice even when eating the same food. When gut bacteria from obese mice were transplanted into germ-free mice, the recipients gained weight without changing their diet. Conversely, bacteria from lean mice kept transplant recipients lean. The microbiome appeared to be transferring a metabolic phenotype.
In humans, studies of obese individuals versus lean individuals consistently find different gut microbiome compositions—though disentangling cause and effect is difficult, since diet changes microbiome changes metabolic function changes obesity. Some researchers believe that certain microbiome compositions extract more calories from the same food—effectively making some people more energetically efficient (unhelpfully so in an obesogenic environment). Faecal microbiota transplants (FMT)—transferring gut bacteria from a healthy donor to a recipient—are being explored as metabolic interventions.
The Gut-Brain Axis: Your Second Brain
Perhaps the most surprising and consequential recent discovery is the extent of communication between gut bacteria and the brain—the gut-brain axis. This bidirectional communication system involves the vagus nerve (the longest cranial nerve, running from brainstem to abdomen), immune signalling molecules, hormones, and neurotransmitters, creating what some researchers call the "second brain" of the enteric nervous system.
The gut contains approximately 500 million neurons—more than the spinal cord—that can operate independently of the brain. These neurons communicate with the brain primarily via the vagus nerve, which carries signals about the gut's microbial environment to brain regions governing mood, stress response, and cognitive function.
The microbiome influences this communication profoundly. Gut bacteria produce neurotransmitters and neurotransmitter precursors: approximately 95% of the body's serotonin is produced in the gut (primarily by enterochromaffin cells, but bacteria influence this production). Gut bacteria also produce GABA, dopamine precursors, and directly stimulate vagal nerve fibres. Changes in gut microbiome composition alter these signals, affecting mood, anxiety, and cognition in animal models.
Human studies, whilst harder to conduct rigorously, find associations between gut microbiome composition and mental health conditions including depression and anxiety. Individuals with major depression consistently show different gut microbiome profiles from healthy controls—though again, causality is difficult to establish (do depressed people have different microbiomes because depression affects their diet and behaviour? Or does the microbiome influence mood?). Experimental support comes from FMT studies: when bacteria from depressed humans are transplanted into germ-free rats, the rats show depressive-like behaviours—suggesting the microbiome contributes to, rather than merely correlates with, mood states.
The emerging field of psychobiotics—probiotics with mental health effects—is attempting to translate these findings into treatments. Certain bacterial strains, consumed as supplements, show modest but real effects on anxiety and depression scores in clinical trials. The mechanisms remain incompletely understood, but the effects appear to involve both direct vagal nerve stimulation and immune modulation.
Dysbiosis: When the Ecosystem Fails
A healthy microbiome is diverse—many species, many functional redundancies, many interconnections. Dysbiosis refers to states of microbial imbalance associated with disease: loss of diversity, overgrowth of certain species, loss of beneficial species, or disruption of normal metabolic outputs.
Antibiotics are the most common cause of dysbiosis in high-income countries. These medicines, lifesaving in many contexts, are profoundly disruptive to gut ecology—they kill not just the target pathogens but much of the collateral gut flora. A single course of broad-spectrum antibiotics can reduce gut bacterial diversity by 30-40%, with some species taking months or years to return. Overuse of antibiotics—for viral infections against which they're ineffective, or as agricultural growth promoters—has been associated with increased rates of inflammatory bowel disease, obesity, allergies, and Clostridioides difficile (C. diff) infections, which exploit the ecological vacuum left by antibiotic treatment.
C. diff infection is a vivid demonstration of microbiome ecology. C. diff bacteria are present in about 5% of healthy adults without causing problems—kept in check by competition from the diverse community of other gut bacteria. When antibiotics kill much of the gut flora, C. diff, which has evolved resistance to many antibiotics, flourishes in the vacant ecological space. The result can be severe, life-threatening diarrhoea. Treatment with faecal microbiota transplant (FMT)—introducing a healthy donor's gut bacteria into the affected patient's colon—restores microbial competition and clears the infection with extraordinary effectiveness, cure rates exceeding 90%, far better than antibiotics alone. FMT for C. diff is now an approved treatment in the UK and US, a striking vindication of the ecological understanding of gut health.
Inflammatory bowel disease (IBD—Crohn's disease and ulcerative colitis) is strongly associated with microbiome dysbiosis. People with IBD have consistently lower microbial diversity and specific changes in community composition compared to healthy controls. Whether dysbiosis causes IBD or results from the inflammatory environment is unclear—likely both, in a vicious cycle. Microbiome-targeted treatments, including FMT and specific probiotic regimes, are being trialled for IBD with promising early results.
Diet, Diversity, and Modifiable Factors
The most actionable finding from microbiome research is that diet is the single most powerful influence on gut microbiome composition—and therefore represents a modifiable lever for gut health.
Dietary fibre is the most important single factor. Gut bacteria ferment fibre; without adequate fibre, populations of fibre-fermenting bacteria decline. Fibre-producing bacteria include those most associated with health benefits: Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii, and others that produce the butyrate essential for colon health. Modern Western diets, low in fibre, are associated with reduced microbiome diversity and lower abundances of these key species. Increasing dietary fibre—through vegetables, wholegrains, legumes, fruits, and nuts—consistently increases microbial diversity in intervention studies.
Dietary diversity matters separately from fibre. Eating many different plant species, even in small amounts, is associated with greater microbiome diversity. A landmark citizen science study found that people eating more than 30 different plant species per week had significantly more diverse gut microbiomes than those eating fewer than 10 species weekly. This diversity threshold—30 plants weekly—has become a practical recommendation from microbiome researchers. Counting plants includes vegetables, fruits, wholegrains, legumes, nuts, seeds, herbs, and spices.
Fermented foods introduce live bacteria directly to the gut. Yoghurt, kefir, kimchi, sauerkraut, miso, and kombucha all contain live bacterial cultures. Whether these introduced bacteria persist in the gut (most don't) or exert effects through immune interactions or metabolite production (they do) remains debated, but high fermented food intake is consistently associated with positive microbiome markers. A Stanford University study found that high fermented food consumption increased microbiome diversity and reduced inflammatory markers more effectively than a high-fibre diet alone.
Sleep, exercise, and stress also influence the microbiome. Chronic stress alters gut motility, immune environment, and microbiome composition through cortisol and the autonomic nervous system. Regular aerobic exercise is consistently associated with greater microbiome diversity, independently of diet. Sleep disruption associated with shift work is linked to dysbiosis patterns resembling those in obesity and metabolic disease.
The Frontier: Cancer, Parkinson's, and Beyond
Microbiome research is rapidly expanding into areas that would have seemed implausible a decade ago.
Cancer immunotherapy response rates are correlated with gut microbiome composition. Patients with diverse, specific gut microbiome profiles respond significantly better to checkpoint inhibitor immunotherapy—drugs that remove "brakes" on the immune system's cancer-fighting capacity. Researchers are investigating whether microbiome modification (through diet, prebiotics, or FMT) could improve immunotherapy response rates—a potential breakthrough in cancer treatment.
Parkinson's disease has connections to the gut that are increasingly hard to dismiss. Parkinson's pathology involves aggregation of a protein called alpha-synuclein in neurons. This aggregation appears to begin in the gut's enteric nervous system and spread to the brain via the vagus nerve—a pattern consistent with gut microbiome triggering or accelerating the disease. Studies find distinct microbiome signatures in Parkinson's patients years before motor symptoms appear. Whether the microbiome is causal or a secondary marker of a common underlying pathology is being investigated urgently.
Alzheimer's disease, like Parkinson's, shows gut microbiome associations. People with Alzheimer's have distinct microbiome profiles from age-matched healthy controls, and mouse models show that transplanting Alzheimer's patients' microbiomes into germ-free mice produces cognitive changes consistent with early neurodegeneration.
These findings are preliminary—correlation rather than causation in most cases—but the consistency across studies and the mechanistic plausibility through the gut-brain axis make them compelling subjects for ongoing research.
Your Microbiome, Your Health
The practical take from microbiome research is both encouraging and appropriately humbled by complexity. The encouraging message: your gut microbiome is modifiable, primarily through diet, and there are evidence-based choices that consistently correlate with healthier microbial communities. The humble caveat: the field is young, individual variation is enormous, and most microbiome supplements sold in pharmacies and health food shops lack robust evidence for specific health benefits.
Eat more plants, more diverse plants, more fermented foods. Avoid unnecessary antibiotics. Exercise regularly. Sleep adequately. Manage stress. These recommendations come from dozens of high-quality studies and happen to align with general health advice from every other perspective.
The deeper lesson from microbiome research is philosophical: we are ecosystems, not individuals. The bacteria in your gut are not separate from you but part of what you are—metabolically active partners in a relationship 3 billion years in the making. Their health and yours are not separate. Their diversity supports your resilience. Their disruption creates your vulnerability.
Understanding this reframes how we think about health, about medicine, and about the boundary between "self" and "other." That boundary, it turns out, is blurrier than biology textbooks implied. You are, gloriously, a community.
